The Bottom Line

Racial and ethnic disparities in dermatology are well-documented and affect millions of patients. From longer wait times and fewer available specialists to misdiagnosis, underrepresentation in clinical trials, and later-stage skin cancer detection, patients of color face systemic barriers to equal skin care. Being informed about these disparities empowers you to seek appropriate care, ask the right questions, and advocate for yourself.

What Are Disparities in Dermatology?

Disparities in dermatology refer to measurable differences in dermatologic care quality, access, and outcomes that correlate with a patient's race, ethnicity, socioeconomic status, or geographic location. These are not individual incidents but patterns documented across multiple studies involving millions of patients.

Key disparity areas include access to care (fewer dermatologists in minority communities), diagnostic accuracy (conditions missed or misidentified on darker skin), treatment outcomes (delayed treatment leads to worse results), research representation (underrepresentation in clinical trials means treatment guidelines may not fully apply), and skin cancer survival (melanoma 5-year survival: 71% for Black patients vs. 94% for white patients, largely due to later detection).

How Disparities Manifest in Patient Experience

Access barriers: Dermatologist density is significantly lower in predominantly minority zip codes. Black patients wait an average of 22% longer for dermatology appointments compared to white patients. Insurance status disparities mean minority patients are more likely to rely on emergency departments rather than preventive dermatologic care.

Diagnostic challenges: Medical education has historically focused on how conditions appear on lighter skin. Only 4.5% of images in major dermatology textbooks show dark skin. This training gap means conditions like eczema (which appears purple-brown rather than red on dark skin), psoriasis (gray-violet rather than pink), and skin cancer can be missed or misidentified.

Treatment differences: Studies show that Black patients with psoriasis are less likely to receive biologic medications than white patients with equal disease severity. Hispanic patients with atopic dermatitis receive fewer specialist referrals. Asian patients may metabolize certain medications differently, but dosing guidelines rarely account for this.

Research gaps: Clinical trials for dermatologic drugs have historically enrolled predominantly white participants. A 2020 analysis found that only 3-5% of participants in pivotal dermatology drug trials were Black, meaning efficacy and safety data may not fully represent the diverse patient population.

Root Causes of Dermatology Disparities

  • Workforce composition: Only ~3% of U.S. dermatologists are Black, ~4.5% are Hispanic — far below population representation. This limits the pool of providers with lived experience treating diverse skin.
  • Educational curriculum gaps: Dermatology textbooks and training programs have historically underrepresented darker skin. Though improving, the effects of decades of training gaps persist in practice.
  • Insurance and economic factors: Uninsured and Medicaid-insured patients face longer wait times and fewer available dermatologists. These economic barriers disproportionately affect minority communities.
  • Geographic maldistribution: Dermatologists cluster in urban, affluent areas. Rural and underserved communities — often with higher minority populations — are underserved.
  • Implicit bias: Like all medical fields, dermatology is not immune to unconscious biases that can affect clinical decision-making, pain assessment, and treatment recommendations.

What You Can Do as a Patient

Find the right provider: Seek dermatologists with skin of color training or interest. Use directories from the Skin of Color Society and Black Derm Directory. Consider teledermatology to expand geographic access.

Prepare for appointments: Document your concerns with photos, timelines, and symptom descriptions. Bring a written list of questions. Don't minimize your symptoms — clearly describe how the condition affects your daily life.

Advocate for yourself: Request a biopsy if a diagnosis is uncertain. Ask about how treatments might affect your skin tone. Seek a second opinion if a diagnosis doesn't match your symptoms or if treatment isn't working after a reasonable period.

Prioritize skin cancer screening: Self-examine your palms, soles, nail beds, and between toes — areas where melanoma most commonly appears in people of color. Request a full-body skin exam from your dermatologist, and remind them to check these less-obvious areas.

When to See a Dermatologist

See a dermatologist — even if access is challenging — for any persistent skin condition that hasn't been diagnosed or isn't improving with current treatment, for new or changing moles or dark spots (especially on palms, soles, or nails), for significant hair loss, and for any skin concern that affects your quality of life. If you face barriers to in-person visits, explore teledermatology options — many dermatologists now offer virtual consultations that can provide expert evaluation regardless of geographic barriers.

Frequently Asked Questions

Are disparities getting better?

Awareness is increasing. More dermatology programs now include skin of color training, several comprehensive textbook and image resources have been published featuring diverse skin, and organizations like the Skin of Color Society are actively working to improve provider education and access. However, systemic changes take time — workforce diversity, geographic distribution, and insurance access improvements are gradual processes.

Does my race affect which skin diseases I'm more likely to get?

Some skin conditions do have different prevalence rates across racial/ethnic groups. For example, keloids are more common in Black and Asian patients, vitiligo is more cosmetically impactful on darker skin, central centrifugal cicatricial alopecia (CCCA) primarily affects Black women, and dermatosis papulosa nigra (small dark bumps) almost exclusively affects Black patients. However, no skin condition is exclusive to one race — any person of any skin tone can develop any skin condition.

Should I participate in clinical trials?

Yes — diverse clinical trial participation is crucial for ensuring that treatments are tested and proven effective across all skin types. If you have a skin condition and are offered the opportunity to participate in a clinical trial, consider it seriously. Your participation helps ensure that future treatments work for patients who look like you. Ask your dermatologist about trials that are actively recruiting diverse participants.

What if I can't find a dermatologist experienced with my skin tone?

Teledermatology has expanded access significantly. Many dermatologists specializing in skin of color offer virtual consultations regardless of where you live. Organizations like the Skin of Color Society, Black Derm Directory, and AAD's Find a Dermatologist tool can help you locate experienced providers. University and academic medical centers often have skin of color clinics staffed by specialists.

References

  1. Buster KJ, Stevens EI, Elmets CA. Dermatologic health disparities. Dermatol Clin. 2012;30(1):53-59.
  2. Adelekun A, Onyekaba G, Lipoff JB. Skin color in dermatology textbooks. J Am Acad Dermatol. 2021;84(1):194-196.
  3. Tripathi R, et al. Demographic and socioeconomic differences in outpatient dermatology services. JAMA Dermatol. 2018;154(11):1286-1291.
  4. Hu S, et al. Melanoma stage at diagnosis among Hispanic, Black, and White patients. Arch Dermatol. 2006;142(6):704-708.

Trusted Resources

Equal skin care is a right, not a privilege. Know the disparities, advocate for yourself, and seek providers who understand your skin.